Tilak Healthcare has secured €10m ($10.52m) in a financing round led by Elaia and Cap Horn to strengthen its ophthalmological telemedicine solution.

Existing investors iBionext and SWEN Capital Partners joined the round, along with Théa, Adelie, and various other ophthalmologists and businesses.

The new capital takes the funds raised by Tilak Healthcare since its inception in 2016 to €22m.

Tilak plans to use the proceeds to expedite the launch of its CE-marked medical device OdySight in France and across the globe.

A remote monitoring system for ophthalmic conditions, OdySight has a gaming interface to aid in remotely analysing age-associated vision problems.  

The company also plans to advance the development of novel offerings for other ailments with the funding.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Under an extended partnership with European ophthalmology laboratory Théa, Tilak Healthcare will roll out OdySight.

Clipperton served as the financial advisor of Tilak Healthcare as part of the investment round.

Tilak Healthcare chair, CEO, and co-founder Edouard Gasser said: “We are very proud to announce this fundraising round and to welcome new investors specialising in digital technologies and healthcare, alongside our long-standing partners who have continued to place their trust in us.

“All our investors share our ambition of revolutionising ophthalmological care through digital technologies and video games, helping to address some of the problems all healthcare systems around the world are facing.”